Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 25 | $20,987,856 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
09 May 2024 17:15 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 May 2024 | Sale | 100 | 44.025 | 4,402 | D |
09 May 2024 17:15 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 May 2024 | Sale | 22,472 | 42.849 | 962,903 | D |
09 May 2024 17:15 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 May 2024 | Sale | 56,335 | 42.1504 | 2,374,543 | D |
09 Apr 2024 16:25 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Apr 2024 | Sale | 4,728 | 54.9152 | 259,639 | D |
09 Apr 2024 16:25 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Apr 2024 | Sale | 64,379 | 54.1165 | 3,483,966 | D |
11 Mar 2024 16:08 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Mar 2024 | Sale | 100 | 63.35 | 6,335 | D |
11 Mar 2024 16:08 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Mar 2024 | Sale | 26,257 | 62.6896 | 1,646,041 | D |
11 Mar 2024 16:08 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Mar 2024 | Sale | 42,750 | 61.8754 | 2,645,173 | D |
13 Feb 2024 16:43 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 12 Feb 2024 | Sale | 1,148 | 67.7669 | 77,796 | D |
31 Jan 2024 16:21 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 29 Jan 2024 | Sale | 874 | 64.1382 | 56,057 | D |
23 Jan 2024 18:03 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 22 Jan 2024 | Sale | 3,913 | 64.996 | 254,329 | D |
17 Jan 2024 16:47 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 16 Jan 2024 | Sale | 1,632 | 66.8086 | 109,032 | D |
09 Nov 2023 16:18 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Nov 2023 | Sale | 12,000 | 47.27 | 567,240 | D |
10 Oct 2023 16:26 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 09 Oct 2023 | Sale | 12,000 | 40.38 | 484,560 | D |
11 Sep 2023 16:58 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Sep 2023 | Sale | 12,000 | 42.87 | 514,440 | D |
09 Aug 2023 16:08 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Aug 2023 | Sale | 12,000 | 23.66 | 283,920 | D |
11 Jul 2023 17:37 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 10 Jul 2023 | Sale | 12,000 | 84.55 | 1,014,600 | D |
09 Jun 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Jun 2023 | Sale | 12,000 | 91.35 | 1,096,200 | D |
09 May 2023 17:02 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 May 2023 | Sale | 12,000 | 92.39 | 1,108,680 | D |
11 Apr 2023 16:20 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 10 Apr 2023 | Sale | 12,000 | 78.21 | 938,520 | D |
10 Mar 2023 17:18 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Mar 2023 | Sale | 12,000 | 63.79 | 765,480 | D |
10 Feb 2023 17:00 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Feb 2023 | Sale | 12,000 | 54.45 | 653,400 | D |
10 Jan 2023 20:07 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 09 Jan 2023 | Sale | 12,000 | 46.08 | 552,960 | D |
12 Dec 2022 16:28 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Dec 2022 | Sale | 12,000 | 47.5 | 570,000 | D |
10 Nov 2022 08:30 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Nov 2022 | Sale | 12,000 | 46.47 | 557,640 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)